spacer
home > ict > spring 2019 > busting the patient engagement myth
PUBLICATIONS
International Clinical Trials

Busting the Patient Engagement Myth

There is no shortage of opinions on how to enrol a clinical study and engage participants. Some may be based on experience, while others may be based on preconceptions, and, in an industry that continues to expand with new players and offerings, it can be hard to differentiate fact from myth. Without methods for challenging or debunking them, these myths can easily be perpetuated, and, for some, they provide an easy and satisfying solution because they are consistent with what they want to believe is true. For others, they are a convenient option when pressed for a solution. However, within the clinical trials arena, relying on myths can be risky when so much is riding on the investment. Developing a process to challenge them can seem daunting, but, with a little insight and a data-driven approach, those working within the industry can feel empowered to do so, creating a solid foundation for clinical trial success.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Aaron Fleishman, Director of Market Development at BBK Worldwide, helps pharmaceutical sponsors, advocacy organisations, and patient thought leaders to create and deploy award-winning, innovative strategies that generate awareness and engagement surrounding clinical research. Aaron’s efforts have resulted in the development of new educational and interactive resources to help improve the overall study participation experience while ensuring that patients and caregivers remain at the centre of every campaign. In 2018, Aaron launched BBK’s Pharma15 Live! web series, a dynamic new format for dialogue within the clinical R&D industry addressing numerous burning issues, including travel services, the patient experience, and disruptive innovations.
spacer
Aaron Fleishman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Cleaning Validation: What do you need to consider to ensure a successful outcome?

RSSL

Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination. The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support. The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues. So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement